Department of Preventive Medicine, Lozano Blesa University Clinical Hospital of Zaragoza , Zaragoza, Spain.
Hum Vaccin Immunother. 2021 Jan 2;17(1):170-172. doi: 10.1080/21645515.2020.1759975. Epub 2020 May 19.
Pneumococcal vaccination is recommended for chronic kidney disease (CKD) patients. We evaluated the impact of implementing a hospital vaccine consultation on their vaccination coverages. A sample was drawn from consecutive cases referred to our clinic between November 2014 and June 2018. 101 patients were analyzed: 4 had received the pneumococcal conjugated vaccine 13-valent at the time of the first appointment, whereas 93 had received it after being seen (RR (95%-CI) = 23.3 (8.88-60.85)). Moreover, 5 had received the pneumococcal polysaccharide vaccine 23-valent at the time of the first appointment, whereas 90 had received it after being seen (RR (95%-CI) = 18.0 (7.64-42.42)). Implementing a hospital-based vaccine consultation represents an effective intervention to improve pneumococcal vaccination coverage in these patients.
肺炎球菌疫苗接种被推荐用于慢性肾脏病(CKD)患者。我们评估了在医院实施疫苗咨询对其疫苗接种覆盖率的影响。该研究从 2014 年 11 月至 2018 年 6 月间连续就诊于我们诊所的患者中抽取了一个样本。共分析了 101 例患者:4 例在首次就诊时已接种 13 价肺炎球菌结合疫苗,而 93 例在就诊后接种(RR(95%CI)= 23.3(8.88-60.85))。此外,5 例在首次就诊时已接种 23 价肺炎球菌多糖疫苗,而 90 例在就诊后接种(RR(95%CI)= 18.0(7.64-42.42))。在医院实施疫苗咨询是提高这些患者肺炎球菌疫苗接种覆盖率的有效干预措施。